期刊文献+

药物共晶的研究新进展 被引量:8

New Research Progress of Pharmaceutical Cocrystals
原文传递
导出
摘要 药物共晶具有调节活性药物成分理化特性的潜力,作为一种可替代活性药物成分的固态形式日益受到关注。针对这一热点问题,研究者们提出了一些新的合成策略和表征技术。基于近10年来药物共晶的研究进展,分别阐述了药物共晶的形成原理、制备方法、表征技术、理化性质和应用前景,介绍了一些新兴技术的应用,并分析了部分研究案例,着重介绍了关于药物共晶的熔点、溶解度、溶出速率、生物利用度、稳定性及机械性能等理化性质的研究。本文旨在归纳总结药物共晶的最新研究进展,为其进一步发展提供参考。 Pharmaceutical cocrystals have the potential to adjust the physicochemical properties of active pharmaceutical ingredient(API),and have attracted increasing attention as the alternative solid forms of APIs.New synthetic strategies and advanced characterization techniques have been proposed in this hot research topic by researchers.On the basis of the research progress of pharmaceutical cocrystals over the last decade,the formation principles,preparation methods,characterization techniques,physicochemical properties and application prospects are described respectively,some research cases are also introduced.This review focuses on melting point,solubility,dissolution rate,bioavailability,stability and mechanical properties of pharmaceutical cocrystals,and summarizes the latest research progress,hoping to provide some references for the further development of pharmaceutical cocrystals.
作者 王礼丽 高紫尧 刘书妤 WANG Lili;GAO Ziyao;LIU Shuyu(School of Chemistry and Chemical Engineering,Shanghai University of Engineering Science,Shanghai 201620)
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2021年第7期881-890,共10页 Chinese Journal of Pharmaceuticals
关键词 活性药物成分 共晶 理化性质 制备 表征 active pharmaceutical ingredient cocrystal physicochemical property preparation characterization
  • 相关文献

参考文献8

二级参考文献145

  • 1王梅,高晓黎.齐墩果酸新型前体脂质体的制备和性质研究[J].中国药学杂志,2007,42(11):839-843. 被引量:12
  • 2Walsh R B, Padgett C W, Metrangolo P, et al. Crystal Growth & Design, 2001, 1(2) : 165-175.
  • 3Oswald I, Motherwell W, Parsons S. Acta Crystallographica Section E: Structure Reports Online, 2004, 60 ( 11 ) : 1967- 1969.
  • 4Almarsson Z M. Chemical Communications, 2004, 1889-1896.
  • 5Caira M. Mol. Pharma. , 2007, 4:310-316.
  • 6Aaker~y C. Acta Crystaltographica Section B: Structural Science, 1997, 53 (4): 569-586.
  • 7Blagden N, De Matas M, Gavan P, et al. Advanced Drug Delivery Reviews, 2007, 59(7): 617-630.
  • 8Huang C, Leiserow L, Schmidt G. J. Chem. Soc. , 1973, 2: 503 -508.
  • 9Remenar J, Morissette S, Peterson M, et al. Journal of the American Chemical Society, 2003, 125 (28) : 8456-8457.
  • 10Childs S, Chyall L, Dunlap J, et al. Journal of the American Chemical Society, 2004, 126(41): 13335-13342.

共引文献87

同被引文献55

引证文献8

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部